Correlation of the European System for Cardiac Operative Risk Evaluation-II (EUROSCORE-II) With Preoperative Score to Predict Post-Operative Mortality (POSPOM) in Cardiac Surgery: A Single Center, Retrospective, Cross- Sectional Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

In cardiac surgery patients, due to the surgical burden combined with existing comorbidities, evaluating the preoperative clinical status of patients and predicting mortality rates has become an important issue of interest for clinicians. For this purpose, mortality has been predicted with various scoring systems. EUROSCORE is a scoring system used worldwide that predicts preoperative mortality for patients undergoing cardiac surgery. POSPOM is a scoring system used for mortality prediction in all surgeries including cardiac surgery. In this study, patients who apply to Istanbul University-Cerrahpasa, Institute of Cardiology between 2020-2024 will be screened.The following will be recorded as postoperative complications: re-sternotomy due to bleeding, re-sternotomy due to mediastinitis, new transient ischemic attack (TIA) or cerebrovascular accident, need for hemofiltration or dialysis, use of an intra-aortic balloon pump, wound infection, sepsis, tracheostomy. The aim of this study is to evaluate the power of POSPOM score in predicting in-hospital mortality in patients undergoing cardiac surgery and its correlation with EUROSCORE-II. Secondarily, it is aimed to investigate postoperative complications after cardiac surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Patients aged 18 and over, patients who have CABG surgery, valve surgery or both, and patients with on-pump surgery will be included in the study.

Locations
Other Locations
Turkey
Istanbul University- Cerrahpasa
RECRUITING
Istanbul
Contact Information
Primary
Gozde Altun, Dr
gozde.altun@iuc.edu.tr
+905544290333
Backup
Kerem Erkalp, Prof
keremerkalp@hotmail.com
+905327879500
Time Frame
Start Date: 2025-01-03
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 315
Treatments
Operation group
Patients aged 18 and over, patients who have CABG surgery, valve surgery or both, and patients with on-pump surgery in 2020-2024 will be included in the study. The sample size was calculated as 314 with an effect size of 0.2, 95% power and 0.05 error level using the G Power 3.1.9.2 package program, taking into account the study of Kaplan et al.
Sponsors
Leads: Istanbul University - Cerrahpasa

This content was sourced from clinicaltrials.gov